Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y M Pinto

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelin-converting enzyme-1 mRNA expression in human cardiovascular diseaseH Bohnemeier, Y M Pinto, F Horkay, et al.
Journal of Cardiovascular Pharmacology|September 28, 1999
Dosing of ACE inhibitors in left ventricular dysfunction: does current clinical dosing provide optimal benefit?Y M Pinto, P P van Geel, H Alkfaji, et al.
Journal of Hypertension|August 24, 2001
Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 geneL Rothermund, Y M Pinto, R Vetter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Increased kallikrein expression protects against cardiac ischemiaY M Pinto, M Bader, J B Pesquero, et al.
Journal of Hypertension|December 30, 1998
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive ratsA C Teisman, Y M Pinto, H Buikema, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 2, 1998
Endothelin converting-enzyme-1 mRNA expression in human cardiovascular diseaseH Bohnemeier, Y M Pinto, F Horkay, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failureY M Pinto, D J van Veldhuisen, R T Tjon-Ka-Jie, et al.
British Journal of Pharmacology|March 21, 1998
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 ratsO Zolk, M Flesch, P Schnabel, et al.
Circulation|September 27, 2000
Cardiac endothelin system impairs left ventricular function in renin-dependent hypertension via decreased sarcoplasmic reticulum Ca(2+) uptakeL Rothermund, Y M Pinto, B Hocher, et al.
Cardiovascular Research|November 1, 1991
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenoprilJ van Wijngaarden, Y M Pinto, W H van Gilst, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelin-converting enzyme-1 mRNA expression in human cardiovascular diseaseH Bohnemeier, Y M Pinto, F Horkay, et al.
Journal of Cardiovascular Pharmacology|September 28, 1999
Dosing of ACE inhibitors in left ventricular dysfunction: does current clinical dosing provide optimal benefit?Y M Pinto, P P van Geel, H Alkfaji, et al.
Journal of Hypertension|August 24, 2001
Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 geneL Rothermund, Y M Pinto, R Vetter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Increased kallikrein expression protects against cardiac ischemiaY M Pinto, M Bader, J B Pesquero, et al.
Journal of Hypertension|December 30, 1998
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive ratsA C Teisman, Y M Pinto, H Buikema, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|June 2, 1998
Endothelin converting-enzyme-1 mRNA expression in human cardiovascular diseaseH Bohnemeier, Y M Pinto, F Horkay, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failureY M Pinto, D J van Veldhuisen, R T Tjon-Ka-Jie, et al.
British Journal of Pharmacology|March 21, 1998
Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 ratsO Zolk, M Flesch, P Schnabel, et al.
Circulation|September 27, 2000
Cardiac endothelin system impairs left ventricular function in renin-dependent hypertension via decreased sarcoplasmic reticulum Ca(2+) uptakeL Rothermund, Y M Pinto, B Hocher, et al.
Cardiovascular Research|November 1, 1991
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenoprilJ van Wijngaarden, Y M Pinto, W H van Gilst, et al.
Pageof 7